The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction
Bin He(Blood Center of Zhejiang Province), Shusen Zheng(Wuhan University)
Cited by 45
Related Papers
Application of metagenomics in the human gut microbiome
|World Journal of Gastroenterology|2015|406
Cancer‐associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma
|Cancer Medicine|2017|211
YAP promotes multi-drug resistance and inhibits autophagy-related cell death in hepatocellular carcinoma via the RAC1-ROS-mTOR pathway
|Cancer Cell International|2019|129
ACSL4 promotes hepatocellular carcinoma progression via c-Myc stability mediated by ERK/FBW7/c-Myc axis
|Oncogenesis|2020|119
MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2
|Journal of Translational Medicine|2014|118